Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9921083 | European Journal of Pharmacology | 2005 | 8 Pages |
Abstract
Peroxisome prolifelator-activated receptor γ (PPARγ) is a ligand-activated transcription factor, through which PPARγ agonists have been demonstrated to down-regulate inflammatory cell functions. Recently, the agonists are reported to exert, in some conditions, their inhibitory actions independently of PPARγ. Previously, we showed that a PPARγ agonist, troglitazone, inhibited cycteinyl (Cys)-leukotrienes production in RBL-2H3 cells after IgE receptor triggering. Here we examined whether the inhibition of cycteinyl-leukotrienes production in the cells was dependent on the activation of PPARγ. A PPARγ agonist, ciglitazone, significantly inhibited Cys-leukotrienes, but not prostaglandin D2, production. The inhibition was not attenuated by the pretreatment with a PPARγ antagonist. Ciglitazone did not alter the mRNA expression of acyl-coenzyme A binding protein, the gene expression of which is up-regulated by PPARγ, nor induce the nucleus translocation of PPARγ. These results suggest that the inhibition by PPARγ agonists of Cys-leukotrienes production in RBL-2H3 cells after IgE receptor triggering is not through the activation of PPARγ.
Keywords
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Kaori Okuyama, Masamichi Yamashita, Yuki Kitabatake, Shunsuke Kawamura, Motoaki Takayanagi, Isao Ohno,